NCT01986660View on ClinicalTrials.gov

Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy
Interventions
DRUG

Ibuprofen Cream (SST-0225)

Trial Locations (1)

Unknown

SST Investigational Site, New York

All Listed Sponsors
lead

Strategic Science & Technologies, LLC

INDUSTRY

NCT01986660 - Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults | Biotech Hunter | Biotech Hunter